Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Launching of the New Version of the MOPH's Website and E-Services Platform

 
The Minister of Public Health Wael Abou Faour launched the updated version of the Ministry’s website www.moph.gov.lb that comprises the completion of the electronic transactions and the publication of drugs prices in comparison with the drugs of similar composition during a press conference held at the Ministry’s premises in Bir-Hasan.
 
The Director of the National E-health Programme Lina Abou Mrad introduced the new structure of the website in details, while she noted that it was developed to keep up with the latest developments. Several elements were added to the website:
 
  1. The official website is now in both English and Arabic languages, after it was only available in English.
  1. The citizen can now be informed on everything issued by the Ministry. The electronic transactions available on the website are now categorized according to the department or subject, which makes it easier for the citizens to search for the transactions or applications.
  1. Eight transactions related to Diwan service, Pharmacy Service, Medical Professions Division and Mother and Child Health Department can be submitted and completed through the internet.
  1. A section is added for the citizens to submit complaints.
  1. The website shows the distribution of all the health care facilities in Lebanon.
  1.  The website provides a detailed description of the drugs, with a national database for the drugs registered at the Ministry and that of similar composition. This database shows all the information related to these drugs, in particular their prices, so as to allow the citizen to compare these prices and that of the drugs of similar composition.
  1.  The website includes a list of the pharmaceutical factories in Lebanon.
 
Abou Mrad added that a page on Facebook has been launched for the activities of the ministry under the title: Lebanese ministry of public health. For breaking news, the ministry can be followed on you tube and mobile app.
 
Minister Abou Faour mentioned the importance of narrowing the distance between the citizen and the state in a country like Lebanon where the gap is large between them. The main purpose of updating the website is to bridge the gap at the communication level especially that the ministry of public health is in daily contact with the citizen.
He also stressed on the importance of the publication of drug prices on the updated website, which makes it easier for the Ministry and the syndicate of pharmacists to prevent illegal pricing.
 
Minister’s decision No. 988 of 08/06/2016 on the adoption of e-services.
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
D06BB03 CIVAR G Aciclovir - 5% 5% Cream 507,972 L.L
D06BB53 ACTI-VIR H G Aciclovir - 5%, Hydrocortisone acetate - 1% Cream 833,182 L.L
D06BB03 CYCLOVEX G Aciclovir - 50mg/g 50mg/g Cream 345,560 L.L
J05AB01 VICLORIX 800 G Aciclovir - 800mg 800mg Tablet 4,321,797 L.L
A07BA01 BIOCARBON B Activated charcoal - 250mg 250mg Tablet 1,158,392 L.L
A03E ACTICARBINE G Activated charcoal - 70mg, Papaverine HCl - 14mg Tablet, coated 306,396 L.L
L04AB04 ADALIREL BioTech Adalimumab - 40mg 40mg Injectable solution L.L
L04AB04 ABRILADA BioTech Adalimumab - 40mg 40mg Injectable solution 40,259,574 L.L
L04AB04 ABRILADA BioTech Adalimumab - 40mg 40mg Injectable solution 40,259,574 L.L
L04AB04 ADALIREL BioTech Adalimumab - 40mg 40mg Injectable solution 7,805,376 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 19,536,163 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 19,536,163 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 34,045,375 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 52,871,023 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 52,871,023 L.L
L04AB04 CINNORA BioTech Adalimumab - 40mg/0.8ml 40mg/0.8ml Injectable solution 14,817,734 L.L
D10AD03 DIFADERM G Adapalene - 0.1% 0.1% Gel 414,671 L.L
D10AD53 EPIDUO B Adapalene - 0.1%, Benzoyl peroxide - 2.5% Gel 2,088,331 L.L
D10AD03 DIFFERIN B Adapalene - 0.1g/100g 0.1% Cream 521,411 L.L
D10AD03 DIFFERIN B Adapalene - 0.1g/100g 0.1% Gel 503,941 L.L
D10AD03 DIFADERM G Adapalene - 0.3% 0.3% Gel 952,208 L.L
D10AD53 EPIDUO FORTE B Adapalene - 0.3%, Benzoyl peroxide - 2.5% Gel 2,201,214 L.L
C01EB10 CARDESINE G Adenosine - 6mg/2ml 6mg/2ml Injectable solution 563,070 L.L
C01CA24 ADRENALINE AGUETTANT G Adrenaline - 0.1mg/ml 0.1mg/ml Injectable solution 13,990,891 L.L
C01CA24 ADRENALINE 1 MG I.V. G Adrenaline - 1mg/ml 1mg/ml Injectable solution 2,239,738 L.L
C01CA24 ADRENALINE SALF G Adrenaline - 1mg/ml 1mg/ml Injectable solution 220,390 L.L
C05CX REPARIL B Aescine - 20mg 20mg Tablet, sugar coated 510,660 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 100mg/4ml 100mg/4ml Injectable concentrate for solution 35,658,713 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 100mg/4ml 100mg/4ml Injectable concentrate for solution 35,658,713 L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026